Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Refrigerate immediately after reconstituting injectable GHK-Cu and use within 28-30 days
PMC Article PMC8337113
Hildebrandt W, Sauer R, Bonaterra G, Dugi KA, Edler L, Kinscherf R
Notably, potassium phosphate is described as acting similarly to GLP-1, suggesting it may function as a GLP-1 agonist
In a subsequent prospective cohort, liraglutide not only improved metabolic parameters but also demonstrated immunomodulatory effects, with a significant reduction in circulating T-cell populations, particularly T cells, which are known to play a key role in PsO pathogenesis by producing IL17 and IL22 ( Successive case reports confirmed the beneficial effects of liraglutide in obese PsO patients without T2DM (52), and a subsequent trial demonstrated marked improvements in PsO symptoms within a few days of treatment, regardless of significant weight loss (50), a result which was later confirmed in other studies (53, 54)
